Nanjing Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nanjing Pharmaceutical Company Limited with three other
companies in this sector in China:
Harbin Pharmaceutical Group Company Limited
sales of 15.85 billion Chinese Renmimbi [US$2.32 billion]
of which 61%
was Medicine Trade),
Sichuan Languang Development Co Ltd
(16.74 billion Chinese Renmimbi [US$2.45 billion]
of which 100%
was Real Estate Development & Management), and
Guangzhou Baiyunshan Pharmceutical Holdings Co Ltd
(19.12 billion Chinese Renmimbi [US$2.80 billion]
of which 41%
Nanjing Pharmaceutical Company Limited reported sales of 24.81 billion Chinese Renmimbi (US$3.63 billion)
December of 2015.
increase of 12.4%
versus 2014, when the company's sales were 22.07 billion Chinese Renmimbi.
Sales at Nanjing Pharmaceutical Company Limited have increased during each of the previous five years
(and since 2010, sales have increased a total of 62%).